Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome - Université de Bretagne Occidentale
Journal Articles New England Journal of Medicine Year : 2018

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory Schwartz
P. Gabriel Steg
  • Function : Author
Michael Szarek
  • Function : Author
Deepak Bhatt
VA Boston Healthcare System
Vera Bittner
  • Function : Author
Rafael Díaz
  • Function : Author
Department of General Surgery. Surgical Oncology Unit
Jay Edelberg
  • Function : Author
Shaun Goodman
  • Function : Author
Corinne Hanotin
  • Function : Author
Robert Harrington
  • Function : Author
J. Wouter Jukema
  • Function : Author
Metacohorts Consortium
Guillaume Lecorps
  • Function : Author
Sanofi [Vitry-sur-Seine]
Kenneth Mahaffey
  • Function : Author
Angèle Moryusef
  • Function : Author
Robert Pordy
  • Function : Author
Kirby Quintero
  • Function : Author
Matthew Roe
  • Function : Author
William Sasiela
  • Function : Author
Jean-François Tamby
  • Function : Author
Pierluigi Tricoci
  • Function : Author
Harvey White
  • Function : Author
Andreas Zeiher
  • Function : Author
Jacques Mansourati
CIC Brest

Domains

Life Sciences [q-bio] Human health and pathology Cardiology and cardiovascular system

Ghislaine Calvez  : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-02059074

Submitted on : Wednesday, March 6, 2019-12:58:53 PM

Last modification on : Wednesday, November 3, 2021-7:53:42 AM

Consult the full text

Dates and versions

hal-02059074 , version 1 (06-03-2019)

Identifiers

Cite

Gregory Schwartz, P. Gabriel Steg, Michael Szarek, Deepak Bhatt, Vera Bittner, et al.. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. New England Journal of Medicine, 2018, 379 (22), pp.2097-2107. ⟨10.1056/NEJMoa1801174⟩. ⟨hal-02059074⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-BREST
27 View
0 Download

Altmetric

Share

More